As of September 30, 2021, Medcolcanna Organics Inc. has 105.72M shares outstanding.
| Shares Outstanding | 105.72M |
These figures are as of September 30, 2021. The price-to-sales ratio is -7.66, and the price-to-book ratio stands at -1.41.
| PS Ratio | -7.66 |
| PB Ratio | -1.41 |
| P/TBV Ratio | -2.59 |
| P/FCF Ratio | -3.93 |
| P/OCF Ratio | -4.07 |
These figures are as of September 30, 2021. Medcolcanna Organics Inc. trades at an EV/FCF ratio of 21.06, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.
| EV / FCF | 21.06 |
As of September 30, 2021, Medcolcanna Organics Inc. maintains a current ratio of 0.20, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -131.09, indicating conservative leverage, while an interest coverage ratio of -8.71 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.20 |
| Quick Ratio | 0.05 |
| Debt / Equity | -131.09 |
| Debt / EBITDA | -0.64 |
| Interest Coverage | -8.71 |
These figures cover the twelve months ended September 30, 2021. Return on assets (ROA) is negative at -129.25, reflecting losses generated across the asset base. Return on capital employed (ROCE) is negative at -349.61, pointing to unprofitable operations over the period. Inventory turnover of 3.08 indicates how many times Medcolcanna Organics Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | -129.25 |
| Return on Capital Employed (ROCE) | -349.61 |
| Inventory Turnover | 3.08 |
Over the twelve months ended September 30, 2021, Medcolcanna Organics Inc. posted a gross margin of 280.98, reflecting its pricing power and cost economics. The operating margin of 682.47 and net profit margin of 720.88 provide insight into operational efficiency.
| Gross Margin | 280.98 |
| Operating Margin | 682.47 |
| Pretax Margin | 733.66 |
| Profit Margin | 720.88 |
| EBITDA Margin | 588.90 |
These figures cover the twelve months ended September 30, 2021. Free cash flow yield is negative at -25.45: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -19.23, meaning Medcolcanna Organics Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -19.23 |
| FCF Yield | -25.45 |
As of September 30, 2021, Medcolcanna Organics Inc. has an Altman Z-Score of -12.28, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -12.28 |
Already premium?